Join the Live #NephTrials Discussion on Efficiency in Clinical Trials: ‘Getting to the H4RT of Registry Design’ on September 29
Connect with Fergus Caskey, Roberto Pecoits-Filho, Michael Walsh, Joel Topf, Manasi Bapat, and Swapnil Hiremath at the latest #NephTrials discussion on September 29, 2022, at 1 p.m. CEST.
Why do we need more efficient clinical trials? What is a registry and why are registries useful? What is a registry-based randomized controlled trial, and how does it differ from a traditional randomized controlled trial?
Find out in the conversation ‘Getting to the H4RT of registry design’ based on the H4RT study comparing high-volume hemodiafiltration and high-flux hemodialysis in people with kidney failure.
The #NephTrials initiative is an exciting series of conversations combining expertise from the ISN-ACT Global Trials Focus, the ISN-ACT Toolkit, and the #NephJC community.
To access the discussion:
- Follow @NephJC and @ISNkidneycare
- Type “NephTrials” in Twitter’s search bar
- Go to “latest”
- Follow the conversation #NephTrials #NephJC
The ISN has designed an easy-to-follow infographic here to help you join the conversation in a few clicks
